You have 9 free searches left this month | for more free features.

acy-1215

Showing 1 - 6 of 6

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Recurrent Chronic Lymphoid Leukemia Trial in Boston (ACY-1215, Ibrutinib, Idelalisib)

Active, not recruiting
  • Recurrent Chronic Lymphoid Leukemia
  • ACY-1215
  • +2 more
  • Boston, Massachusetts
    Dana Farber Cancer Institute
Jun 13, 2022

Multiple Myeloma Trial in United States (ACY-1215, lenalidomide, Dexamethasone)

Completed
  • Multiple Myeloma
  • ACY-1215
  • +2 more
  • Boston, Massachusetts
  • +4 more
Feb 7, 2022

Metastatic Breast Cancer, Breast Carcinoma Trial in New York (ACY-1215, Nab-paclitaxel)

Completed
  • Metastatic Breast Cancer
  • Breast Carcinoma
  • New York, New York
    Columbia Irving University Medical Center
Jan 5, 2021

Lymphoma, Lymphoid Malignancies Trial in Tampa, New York (ACY-1215)

Completed
  • Lymphoma
  • Lymphoid Malignancies
  • ACY-1215
  • Tampa, Florida
  • +1 more
Feb 6, 2020

Multiple Myeloma Trial in United States (ACY-1215)

Completed
  • Multiple Myeloma
  • ACY-1215
  • Atlanta, Georgia
  • +5 more
Apr 5, 2017

Healthy Trial in Madison (ACY-1215)

Completed
  • Healthy
  • ACY-1215
  • Madison, Wisconsin
    Covance Clinical Research Unit Incorporated
Sep 10, 2014